In a significant advancement for neuro-oncology, a collaborative team of scientists in Canada has uncovered a novel mechanism to impede…
Read More
Boehringer Ingelheim and Zai Lab Forge Clinical Collaboration to Pioneer Novel Combination Therapy for Aggressive Lung Cancers
Boehringer Ingelheim and Zai Lab have announced a significant clinical collaboration aimed at investigating a dual delta-like ligand 3 (DLL3)-targeting…
Read More
Canadian Researchers Identify Potential HIV Drug Repurposing to Combat Aggressive Glioblastoma Brain Tumors
In a landmark study that could redefine the treatment landscape for terminal brain cancer, a collaborative team of Canadian scientists…
Read More
Glioblastoma Research Reveals Skull Bone Erosion and Immune System Manipulation by Aggressive Brain Tumors
In a landmark study published on October 3 in the journal Nature Neuroscience, researchers from the Montefiore Einstein Comprehensive Cancer…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
The persistence of estrogen receptor-positive (ER+) breast cancer remains one of the most formidable challenges in modern oncology, as patients…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
The phenomenon of cancer recurrence remains one of the most significant challenges in modern oncology, particularly in the context of…
Read MoreYOU MAY HAVE MISSED
